- Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
-
Kandeel M, Yamamoto M, Tani H, Kobayashi A, Gohda J, Kawaguchi Y, Park BK, Kwon HJ, Inoue Ji, Alkattan A
- KMID: 2515276
- Biomol Ther.
- 2021 May;29(3):282-289.
- doi: 10.4062/biomolther.2020.201
A novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), caused a worldwide pandemic. Our aim in this study is to produce new fusion inhibitors against SARS-CoV-2, which can be the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series
-
Tani H, Tomita M, Suzuki T, Mimura M, Uchida H
- KMID: 2522990
- Clin Psychopharmacol Neurosci.
- 2021 Nov;19(4):773-779.
- doi: 10.9758/cpn.2021.19.4.773
Objective: While antipsychotics are necessary for relapse prevention in the treatment of schizophrenia in general, some minority of patients may be maintained without continuous antipsychotic treatment. However, the characteristics of... -
- CITED
-
- Close
- SHARE
-
- Close
